Amit B. Shah - Net Worth and Insider Trading
Amit B. Shah Net Worth
The estimated net worth of Amit B. Shah is at least $1,242 dollars as of 2024-08-25. Amit B. Shah is the CHIEF FINANCIAL OFFICER of Oncotelic Therapeutics Inc and owns about 60,000 shares of Oncotelic Therapeutics Inc (OTLC) stock worth over $1,242. Details can be seen in Amit B. Shah's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Amit B. Shah has not made any transactions after 2020-11-24 and currently still holds the listed stock(s).
Transaction Summary of Amit B. Shah
Amit B. Shah Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Amit B. Shah owns 2 companies in total, including Adhera Therapeutics Inc (ATRX) , and Oncotelic Therapeutics Inc (OTLC) .
Click here to see the complete history of Amit B. Shah’s form 4 insider trades.
Insider Ownership Summary of Amit B. Shah
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ATRX | Adhera Therapeutics Inc | 2017-10-02 | Chief Financial Officer |
OTLC | Oncotelic Therapeutics Inc | 2020-11-24 | CHIEF FINANCIAL OFFICER |
Amit B. Shah Latest Holdings Summary
Amit B. Shah currently owns a total of 1 stock. Amit B. Shah owns 60,000 shares of Oncotelic Therapeutics Inc (OTLC) as of November 24, 2020, with a value of $1,242.
Latest Holdings of Amit B. Shah
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
OTLC | Oncotelic Therapeutics Inc | 2020-11-24 | 60,000 | 0.02 | 1,242 |
Holding Weightings of Amit B. Shah
Amit B. Shah Form 4 Trading Tracker
According to the SEC Form 4 filings, Amit B. Shah has made a total of 1 transactions in Oncotelic Therapeutics Inc (OTLC) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Oncotelic Therapeutics Inc is the acquisition of 60,000 shares on November 24, 2020, which cost Amit B. Shah around $11,400.
Insider Trading History of Amit B. Shah
- 1
Amit B. Shah Trading Performance
GuruFocus tracks the stock performance after each of Amit B. Shah's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Amit B. Shah is 48.27%. GuruFocus also compares Amit B. Shah's trading performance to market benchmark return within the same time period. The performance of stocks bought by Amit B. Shah within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Amit B. Shah's insider trading performs compared to the benchmark.
Amit B. Shah Ownership Network
Ownership Network List of Amit B. Shah
Ownership Network Relation of Amit B. Shah
![Insider Network Chart](https://static.gurufocus.com/insider-network.png)
Amit B. Shah Owned Company Details
What does Adhera Therapeutics Inc do?
Who are the key executives at Adhera Therapeutics Inc?
Amit B. Shah is the Chief Financial Officer of Adhera Therapeutics Inc. Other key executives at Adhera Therapeutics Inc include director & Chief Executive Officer Andrew Albert Kucharchuk , SVP Finance & Accounting Rhonda L. Stanley , and Chief Financial Officer Robert Eric Teague .
Adhera Therapeutics Inc (ATRX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Adhera Therapeutics Inc (ATRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Adhera Therapeutics Inc (ATRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Adhera Therapeutics Inc (ATRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Adhera Therapeutics Inc Insider Transactions
Amit B. Shah Mailing Address
Above is the net worth, insider trading, and ownership report for Amit B. Shah. You might contact Amit B. Shah via mailing address: 10 Aguila, Aliso Viejo Ca 92656.